242 related articles for article (PubMed ID: 20876458)
21. Enrichment of FLI1 and RUNX1 mutations in families with excessive bleeding and platelet dense granule secretion defects.
Stockley J; Morgan NV; Bem D; Lowe GC; Lordkipanidzé M; Dawood B; Simpson MA; Macfarlane K; Horner K; Leo VC; Talks K; Motwani J; Wilde JT; Collins PW; Makris M; Watson SP; Daly ME;
Blood; 2013 Dec; 122(25):4090-3. PubMed ID: 24100448
[TBL] [Abstract][Full Text] [Related]
22. Platelet transcriptome analysis in patients with germline RUNX1 mutations.
Palma-Barqueros V; Bastida JM; López Andreo MJ; Zámora-Cánovas A; Zaninetti C; Ruiz-Pividal JF; Bohdan N; Padilla J; Teruel-Montoya R; Marín-Quilez A; Revilla N; Sánchez-Fuentes A; Rodriguez-Alen A; Benito R; Vicente V; Iturbe T; Greinacher A; Lozano ML; Rivera J; ;
J Thromb Haemost; 2023 May; 21(5):1352-1365. PubMed ID: 36736831
[TBL] [Abstract][Full Text] [Related]
23. Haematological spectrum and genotype-phenotype correlations in nine unrelated families with RUNX1 mutations from the French network on inherited platelet disorders.
Latger-Cannard V; Philippe C; Bouquet A; Baccini V; Alessi MC; Ankri A; Bauters A; Bayart S; Cornillet-Lefebvre P; Daliphard S; Mozziconacci MJ; Renneville A; Ballerini P; Leverger G; Sobol H; Jonveaux P; Preudhomme C; Nurden P; Lecompte T; Favier R
Orphanet J Rare Dis; 2016 Apr; 11():49. PubMed ID: 27112265
[TBL] [Abstract][Full Text] [Related]
24. Functional classification of RUNX1 variants in familial platelet disorder with associated myeloid malignancies.
Decker M; Lammens T; Ferster A; Erlacher M; Yoshimi A; Niemeyer CM; Ernst MPT; Raaijmakers MHGP; Duployez N; Flaum A; Steinemann D; Schlegelberger B; Illig T; Ripperger T
Leukemia; 2021 Nov; 35(11):3304-3308. PubMed ID: 33692461
[No Abstract] [Full Text] [Related]
25. Targeted gene correction of RUNX1 in induced pluripotent stem cells derived from familial platelet disorder with propensity to myeloid malignancy restores normal megakaryopoiesis.
Iizuka H; Kagoya Y; Kataoka K; Yoshimi A; Miyauchi M; Taoka K; Kumano K; Yamamoto T; Hotta A; Arai S; Kurokawa M
Exp Hematol; 2015 Oct; 43(10):849-57. PubMed ID: 26021490
[TBL] [Abstract][Full Text] [Related]
26. Systems Pharmacogenomics Finds RUNX1 Is an Aspirin-Responsive Transcription Factor Linked to Cardiovascular Disease and Colon Cancer.
Voora D; Rao AK; Jalagadugula GS; Myers R; Harris E; Ortel TL; Ginsburg GS
EBioMedicine; 2016 Sep; 11():157-164. PubMed ID: 27566955
[TBL] [Abstract][Full Text] [Related]
27. Mouse RUNX1C regulates premegakaryocytic/erythroid output and maintains survival of megakaryocyte progenitors.
Draper JE; Sroczynska P; Leong HS; Fadlullah MZH; Miller C; Kouskoff V; Lacaud G
Blood; 2017 Jul; 130(3):271-284. PubMed ID: 28490570
[TBL] [Abstract][Full Text] [Related]
28. Role of oculocerebrorenal syndrome of Lowe (OCRL) protein in megakaryocyte maturation, platelet production and functions: a study in patients with Lowe syndrome.
Egot M; Lasne D; Poirault-Chassac S; Mirault T; Pidard D; Dreano E; Elie C; Gandrille S; Marchelli A; Baruch D; Rendu J; Fauré J; Flaujac C; Gratacap MP; Sié P; Gaussem P; Salomon R; Baujat G; Bachelot-Loza C
Br J Haematol; 2021 Mar; 192(5):909-921. PubMed ID: 33528045
[TBL] [Abstract][Full Text] [Related]
29. Spectrum of clinical and genetic features of patients with inherited platelet disorder with suspected predisposition to hematological malignancies: a nationwide survey in Japan.
Yoshimi A; Toya T; Nannya Y; Takaoka K; Kirito K; Ito E; Nakajima H; Hayashi Y; Takahashi T; Moriya-Saito A; Suzuki K; Harada H; Komatsu N; Usuki K; Ichikawa M; Kurokawa M
Ann Oncol; 2016 May; 27(5):887-95. PubMed ID: 26884589
[TBL] [Abstract][Full Text] [Related]
30. In vitro analyses of known and novel RUNX1/AML1 mutations in dominant familial platelet disorder with predisposition to acute myelogenous leukemia: implications for mechanisms of pathogenesis.
Michaud J; Wu F; Osato M; Cottles GM; Yanagida M; Asou N; Shigesada K; Ito Y; Benson KF; Raskind WH; Rossier C; Antonarakis SE; Israels S; McNicol A; Weiss H; Horwitz M; Scott HS
Blood; 2002 Feb; 99(4):1364-72. PubMed ID: 11830488
[TBL] [Abstract][Full Text] [Related]
31. Functional characterization of the promoter region of the human EVI1 gene in acute myeloid leukemia: RUNX1 and ELK1 directly regulate its transcription.
Maicas M; Vázquez I; Vicente C; García-Sánchez MA; Marcotegui N; Urquiza L; Calasanz MJ; Odero MD
Oncogene; 2013 Apr; 32(16):2069-78. PubMed ID: 22689058
[TBL] [Abstract][Full Text] [Related]
32. Bone Marrow Morphology Associated With Germline
Chisholm KM; Denton C; Keel S; Geddis AE; Xu M; Appel BE; Cantor AB; Fleming MD; Shimamura A
Pediatr Dev Pathol; 2019; 22(4):315-328. PubMed ID: 30600763
[TBL] [Abstract][Full Text] [Related]
33. Restoring RUNX1 deficiency in RUNX1 familial platelet disorder by inhibiting its degradation.
Krutein MC; Hart MR; Anderson DJ; Jeffery J; Kotini AG; Dai J; Chien S; DelPriore M; Borst S; Maguire JA; French DL; Gadue P; Papapetrou EP; Keel SB; Becker PS; Horwitz MS
Blood Adv; 2021 Feb; 5(3):687-699. PubMed ID: 33560381
[TBL] [Abstract][Full Text] [Related]
34. Gene of the issue: RUNX1 mutations and inherited bleeding.
Morgan NV; Daly ME
Platelets; 2017 Mar; 28(2):208-210. PubMed ID: 28277065
[No Abstract] [Full Text] [Related]
35. Clinical phenotype of germline RUNX1 haploinsufficiency: from point mutations to large genomic deletions.
Béri-Dexheimer M; Latger-Cannard V; Philippe C; Bonnet C; Chambon P; Roth V; Grégoire MJ; Bordigoni P; Lecompte T; Leheup B; Jonveaux P
Eur J Hum Genet; 2008 Aug; 16(8):1014-8. PubMed ID: 18478040
[TBL] [Abstract][Full Text] [Related]
36. Familial platelet disorder due to germline exonic deletions in
Engvall M; Karlsson Y; Kuchinskaya E; Jörnegren Å; Mathot L; Pandzic T; Palle J; Ljungström V; Cavelier L; Hellström Lindberg E; Cammenga J; Baliakas P
Leuk Lymphoma; 2022 Oct; 63(10):2311-2320. PubMed ID: 35533071
[TBL] [Abstract][Full Text] [Related]
37. Inherited platelet dysfunction and hematopoietic transcription factor mutations.
Songdej N; Rao AK
Platelets; 2017 Jan; 28(1):20-26. PubMed ID: 27463948
[TBL] [Abstract][Full Text] [Related]
38. Transcriptional Auto-Regulation of RUNX1 P1 Promoter.
Martinez M; Hinojosa M; Trombly D; Morin V; Stein J; Stein G; Javed A; Gutierrez SE
PLoS One; 2016; 11(2):e0149119. PubMed ID: 26901859
[TBL] [Abstract][Full Text] [Related]
39. Runx1 is a co-activator with FOXO3 to mediate transforming growth factor beta (TGFbeta)-induced Bim transcription in hepatic cells.
Wildey GM; Howe PH
J Biol Chem; 2009 Jul; 284(30):20227-39. PubMed ID: 19494111
[TBL] [Abstract][Full Text] [Related]
40. Study of inherited thrombocytopenia resulting from mutations in ETV6 or RUNX1 using a human pluripotent stem cell model.
Borst S; Nations CC; Klein JG; Pavani G; Maguire JA; Camire RM; Drazer MW; Godley LA; French DL; Poncz M; Gadue P
Stem Cell Reports; 2021 Jun; 16(6):1458-1467. PubMed ID: 34019812
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]